Timetable

09:00-09:15 Official opening
09:15-09:40 Tobias Bald
University of Bonn, Germany
NK cell plasticity in cancer
09:40-10:05 Kazuyo Moro
RIKEN/Osaka University, Japan
The Impact of Appendectomy on Ulcerative Colitis
10:05-10:30 Jakub Gołąb
Medical University of Warsaw, Poland
The roles of arginases in mitigation of antitumor immunity
10:30-10:55 Aurélie Poli
Luxembourg Institute of Health, Luxembourg
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
10:55-11:20 Alexandros Drainas
BioMed X, Germany
The quest to eliminate ecDNA in cancer cells
11:20-11:40 Break
11:40-12:05 Andrew Shepherd
University of Texas MD Anderson Cancer Center, USA
Pain neurons control cancer immunosurveillance
12:05-12:30 Hrvoje Miletic
University of Bergen, Norway
Cell communication and mitochondria transfer in brain tumors
12:30-12:55 Anne-Marie Heegaard
University of Copenhagen, Denmark
Pain in Multiple Myeloma – interaction of the cancer microenvironment with the sensory nervous system
12:55-13:20 Sébastien Talbot (online)
Queen’s University, ON, Canada
Peripheral Nerve Injury Induced by Colorectal Cancer: Mechanisms and Implications for Chemotherapy-Induced Peripheral Neuropathy
13:20-13:30 Sponsor presentation: Altium
13:30-14:30 Lunch
14:30-14:55 Claudio Ballabio
The Francis Crick Institute, United Kingdom
Tumour intrinsic electrical activity drives small-cell lung cancer progression
14:55-15:20 Yuan Pan (online)
University of Texas MD Anderson Cancer Center, USA
The Cancer Neuroscience of Neurofibromatosis type 1 (NF1)
15:20-15:45 Dominika Nowis
Medical University of Warsaw, Poland
The use of mRNA-based immunotherapies in experimental oncology
15:45-16:10 Helena Florindo
University of Lisbon, Portugal
Unveiling Solid Tumor Microenvironment for revolutionary nano-immunotherapies
16:10-17:00 Break (Industry Contact Point introduction to Matchmaking + Matchmaking Session)
17:00-18:00 Opening Keynote Melody Swartz
University of Chicago, USA
The yin and yang of tumor-associated lymphatics in metastasis and anti-tumor immunity

09:00-10:30 EIT Health – Morning Health Talks
EIT Morning Talks Monika Ślęzak (panel moderator)
Industry Contact Point Medical Technologies and Health, Łukasiewicz – PORT

Marek Kozłowski
Venture Capital – Life Science & Healthcare NRW.Venture

Michał Malewicz
Life Science & Biotechnology Center, Łukasiewicz – PORT

Michał Zawisza Woyczyński
Saving Kids with Cancer Foundation

Marek Sipowicz
WPD Pharmaceuticals Inc.

Monika Litwin
Lower Silesian Center of Oncology, Pulmonology and Hematology

Magdalena Sobocińska
NU-MED Specialist Oncology Hospital in Tomaszów Mazowiecki

Magdalena Ciążyńska
NU-MED Specialist Oncology Hospital in Tomaszów Mazowiecki
10:30-10:40 Break
10:40-11:05 Carlos-Filipe Pereira
Lund University, Sweden
Empowering Cancer Immunotherapy with Cellular Reprogramming
11:05-11:30 Rafael Blanco Domínguez
University of Lisbon, Portugal
Delta One T cells in Cancer Immunotherapy
11:30-11:55 Helen Kakkassery
King’s College London, United Kingdom
Investigating the immune surveillance mechanisms in atypical responders of stage IV breast cancers following standard of care chemo – and targeted therapies
11:55-12:55 Conference brunch
12:55-13:20 Thanussuyah Alaguthurai
King’s College London, United Kingdom
Translational Research Programme- Facilitating oncology research at Guy’s
13:20-13:45 Marco Gustav
Dresden University of Technology, Germany
Deep Learning-based Biomarkers for Precision Oncology
13:45-13:55 Break
13:55-14:20 Christoph Klose
Charité – Berlin University Medicine, Germany
Neuro-immune interactions at barrier surfaces
14:20-14:45 Bożena Kamińska
Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Poland
Taming tumor microenvironment with siRNAs and innovative nanocarriers in malignant gliomas
14:45-15:55 Company session
Molecure, Celon Pharma, Ryvu Therapeutics, International Centre for Cancer Vaccine Science (University of Gdańsk), Ardigen, Cellis, Cancer Center
15:55-16:00 Official closure
Skip to content